A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis.

Clinical trial NCT01863771 · COMPLETED

Trial details

NCT number: NCT01863771
Sponsor: Janssen Pharmaceutical K.K.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Colitis, Ulcerative

Start date: 2013-03-15
Primary completion: 2016-01-29
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.